FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Insulin Glargine-aglr Injection

  • U.S. Food and Drug Administration
  • September 1, 2026
  • ID: shortage-insulin-glargine-aglr-injection-eli-lilly-and-co-0002-8980-05

Drug Shortage Details

Generic NameInsulin Glargine-aglr Injection
Manufacturer / CompanyEli Lilly and Co.
Therapeutic CategoryEndocrinology/Metabolism
Availability StatusShortage
Status (FDA list)To Be Discontinued
NDC Package Code0002-8980-05
Presentation & Dosage Form

Rezvoglar, Injection, 100 [iU]/1 mL (NDC 0002-8980-05)

Manufacturer Contact Info

800-545-5979


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.